The current CNC market cap is 39.14B. The company's latest EPS is USD 5.1366 and P/E is 14.48.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 37.61B | 38.04B | 39.46B | 40.41B | 39.84B |
Operating Income | 1.19B | 1.18B | -143M | 1.12B | 1.23B |
Net Income | 1.06B | 469M | 45M | 1.16B | 1.15B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 74.64B | 111.12B | 125.98B | 144.55B | 154B |
Operating Income | 1.78B | 3.08B | 1.78B | 3.64B | 3.46B |
Net Income | 1.32B | 1.81B | 1.35B | 1.2B | 2.7B |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 82.85B | 84.38B | 84.64B | 82.62B | 83.14B |
Total Liabilities | 57.07B | 58.97B | 58.69B | 55.56B | 55.68B |
Total Equity | 25.77B | 25.4B | 25.94B | 27.05B | 27.44B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 40.99B | 68.72B | 78.38B | 76.87B | 84.64B |
Total Liabilities | 28.3B | 42.76B | 51.35B | 52.63B | 58.69B |
Total Equity | 12.66B | 25.89B | 26.94B | 24.18B | 25.94B |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 6.82B | 7.84B | 8.05B | -456M | 1.72B |
Investing | -677M | -242M | -1.19B | 852M | -315M |
Financing | -933M | -1.46B | -1.66B | 23M | -1.15B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 1.48B | 5.5B | 4.21B | 6.26B | 8.05B |
Investing | -1.53B | -6.96B | -3.3B | -2.92B | -1.19B |
Financing | 6.83B | 260M | 1.36B | -4.2B | -1.66B |
Market Cap | 39.14B |
Price to Earnings Ratio | 14.48 |
Price to Sales Ratio | 0.25 |
Price to Cash Ratio | 2.28 |
Price to Book Ratio | 1.51 |
Dividend Yield | - |
Shares Outstanding | 526.03M |
Average Volume (1 week) | 4.46M |
Average Volume (1 Month) | 4.39M |
52 Week Change | 8.14% |
52 Week High | 81.415 |
52 Week Low | 63.45 |
Spread (Intraday) | 2.39 (3.15%) |
Company Name | Centene Corp |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.centene.com |
Industry | hospital & medical svc plans (6324) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.